Medtronic plc. Ordinary Shares (MDT) Reaches $89.48 High on Jun, 20; Tpg Group Holdings Sbs Advisors Trimmed By $1.80 Million Its Caredx (CDNA) Stake

June 20, 2017 - By Peter Erickson

The stock of Medtronic plc. Ordinary Shares (NYSE:MDT) reached all time high today, Jun, 20 and still has $93.95 target or 5.00% above today’s $89.48 share price. This indicates more upside for the $121.82 billion company. This technical setup was reported by Barchart.com. If the $93.95 PT is reached, the company will be worth $6.09 billion more. About 554,438 shares traded. Medtronic plc. Ordinary Shares (NYSE:MDT) has risen 4.04% since June 20, 2016 and is uptrending. It has underperformed by 12.66% the S&P500.

Tpg Group Holdings Sbs Advisors Inc decreased Caredx Inc. (CDNA) stake by 83.78% reported in 2016Q4 SEC filing. Tpg Group Holdings Sbs Advisors Inc sold 900,712 shares as Caredx Inc. (CDNA)’s stock declined 53.04%. The Tpg Group Holdings Sbs Advisors Inc holds 174,378 shares with $471,000 value, down from 1.08 million last quarter. Caredx Inc. now has $23.35 million valuation. The stock rose 0.92% or $0.01 reaching $1.1. About 175 shares traded. CareDx Inc (NASDAQ:CDNA) has declined 74.10% since June 20, 2016 and is downtrending. It has underperformed by 90.80% the S&P500.

Among 25 analysts covering Medtronic (NYSE:MDT), 16 have Buy rating, 0 Sell and 9 Hold. Therefore 64% are positive. Medtronic had 41 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Medtronic plc. Ordinary Shares (NYSE:MDT) has “Buy” rating given on Friday, February 17 by UBS. The firm has “Outperform” rating by Credit Suisse given on Monday, August 10. SunTrust maintained the stock with “Buy” rating in Monday, June 13 report. Credit Suisse maintained Medtronic plc. Ordinary Shares (NYSE:MDT) rating on Monday, November 23. Credit Suisse has “Outperform” rating and $85 target. Goldman Sachs upgraded Medtronic plc. Ordinary Shares (NYSE:MDT) on Friday, November 13 to “Conviction Buy List” rating. The rating was maintained by Stifel Nicolaus with “Hold” on Thursday, May 25. The stock of Medtronic plc. Ordinary Shares (NYSE:MDT) earned “Outperform” rating by RBC Capital Markets on Tuesday, September 29. The stock has “Buy” rating by Deutsche Bank on Thursday, June 2. On Friday, August 26 the stock rating was maintained by Jefferies with “Buy”. Stifel Nicolaus maintained it with “Hold” rating and $81 target in Wednesday, November 23 report.

Investors sentiment increased to 0.81 in 2016 Q4. Its up 0.08, from 0.73 in 2016Q3. It is positive, as 115 investors sold Medtronic plc. Ordinary Shares shares while 468 reduced holdings. 123 funds opened positions while 351 raised stakes. 1.09 billion shares or 8.84% more from 999.44 million shares in 2016Q3 were reported. Moreover, Homrich Berg has 0.03% invested in Medtronic plc. Ordinary Shares (NYSE:MDT) for 4,193 shares. Compton Inc Ri reported 1.12% stake. Argyle Cap invested 1.43% of its portfolio in Medtronic plc. Ordinary Shares (NYSE:MDT). Lazard Asset Mngmt Ltd Liability Co invested 0.19% of its portfolio in Medtronic plc. Ordinary Shares (NYSE:MDT). Flossbach Von Storch Ag reported 1.96M shares. 6,917 were accumulated by Kingfisher Cap Limited Liability Com. Sun Life has 0% invested in Medtronic plc. Ordinary Shares (NYSE:MDT). East Coast Asset Management Limited holds 0.09% of its portfolio in Medtronic plc. Ordinary Shares (NYSE:MDT) for 3,998 shares. 153,256 are owned by Obermeyer Wood Inv Counsel Lllp. Neuberger Berman Ltd invested 0.19% of its portfolio in Medtronic plc. Ordinary Shares (NYSE:MDT). Liberty Cap Management reported 1,450 shares. 3,444 are owned by Amg National Bank. 5,074 are held by Modera Wealth Mngmt. Blackrock Gp reported 0.43% stake. Aperio Grp Incorporated Ltd Liability Company owns 333,082 shares.

Tpg Group Holdings Sbs Advisors Inc increased Continental Bldg Prods Inc. (NYSE:CBPX) stake by 36,223 shares to 754,815 valued at $17.44M in 2016Q4. It also upped Quintiles Ims Holdings Inc. (NYSE:Q) stake by 42.52 million shares and now owns 49.65 million shares. Pegasystems Inc. (NASDAQ:PEGA) was raised too.

Investors sentiment decreased to 1.63 in 2016 Q4. Its down 0.08, from 1.71 in 2016Q3. It dropped, as 1 investors sold CDNA shares while 7 reduced holdings. 8 funds opened positions while 5 raised stakes. 7.74 million shares or 4.10% less from 8.07 million shares in 2016Q3 were reported. California Pub Employees Retirement Sys owns 175,000 shares or 0% of their US portfolio. Deutsche National Bank & Trust Ag, a Germany-based fund reported 141 shares. Paragon Associates Paragon Associates Ii Joint Venture reported 1.47M shares. Highland Ltd Partnership stated it has 0.2% of its portfolio in CareDx Inc (NASDAQ:CDNA). Thompson Davis & Co invested in 2,000 shares or 0.01% of the stock. Teton Advsr Incorporated reported 0% of its portfolio in CareDx Inc (NASDAQ:CDNA). State Bank Of America Corp De owns 63 shares. New York-based M&T Savings Bank has invested 0% in CareDx Inc (NASDAQ:CDNA). Ontario Teachers Pension Plan Board reported 0.01% stake. Blackrock Investment Mngmt Limited Liability Corporation reported 1,928 shares. Tower Rech Limited (Trc) holds 0% or 3,717 shares in its portfolio. 57,300 were accumulated by Spark Inv Mgmt Limited Liability Com. Moreover, Intl Incorporated has 0% invested in CareDx Inc (NASDAQ:CDNA) for 64,570 shares. Morgan Stanley invested in 0% or 700 shares. Tpg Hldgs (Sbs) Advsrs Inc reported 0.01% stake.

Among 3 analysts covering CareDx (NASDAQ:CDNA), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. CareDx had 4 analyst reports since September 25, 2015 according to SRatingsIntel. Craig Hallum initiated the stock with “Buy” rating in Friday, September 25 report. The firm has “Buy” rating given on Tuesday, June 14 by Mizuho. Raymond James downgraded the shares of CDNA in report on Monday, September 28 to “Market Perform” rating.

Since January 20, 2017, it had 3 buys, and 0 selling transactions for $239,651 activity. GAGNON NEIL bought $7,109 worth of stock.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: